[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-detail-335608-en":59,"doc-seo-335608-105":81},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":5,"data":60},{"doc_id":61,"user_id":62,"nickname":63,"user_avatar":64,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":66,"doc_content":67,"file_id":68,"file_url":69,"file_type":70,"file_size":71,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":72,"language":73,"language_code":74,"site_id":75,"html_lang":74,"table_of_contents":76,"faqs":77,"seo_title":78,"seo_description":66,"update_tm":79,"read_time":80,"preview_page_count":4},335608,13056703019662,"Evangeline","https://ap-avatar.wpscdn.com/avatar/be000253a8e92610077?_k=1778726343310543188","Image analysis-based identification of high risk ER-positive, HER2-negative breast cancers - Research Open Access","Background: Breast cancer subtypes Luminal A and Luminal B are classified by PAM50 gene expression and may require different treatment strategies. Image-based machine learning using H&E slides may reveal subtype-associated patterns for early identification of tumors with higher recurrence risk. Methods: ER+/HER2-breast cancers were segmented into epithelium and stroma; CNN and multiple instance learning extracted features from original and segmented images. Patient-level models discriminated Luminal A versus B features with tenfold cross-validation, with or without grade adjustment. Results: Visual protocols differentiated recurrence times with risk estimates similar to PAM50, and grade adjustment balanced sensitivity and specificity. Conclusions: Given low genomic test uptake, imaging approaches may help identify ER+/HER2-patients who could benefit from testing.","Lee et al. Breast Cancer Research (2024) 26:177 [https://doi.org/10.1186/s13058-024-01915-5](https://doi.org/10.1186/s13058-024-01915-5)  \nBreast Cancer Research  \n RESEARCH Open Access  \nImage analysis-based identification of high   risk ER-positive, HER2-negative breast cancers  \nDong Neuck Lee1, Yao Li2, LinneaT. Olsson3, Alina M. Hamilton4, Benjamin C. Calhoun6, Katherine A. Hoadley5, J. S. Marron2* and Melissa A. Troester3*  \nAbstract  \nBackground Breast cancer subtypes Luminal A and Luminal B are classified by the expression of PAM50 genes and may benefit from different treatment strategies. Machine learning models based on H&E images may contain features associated with subtype, allowing early identification of tumors with higher risk of recurrence.  \nMethods H&E images (n = 630 ER+/HER2-breast cancers) were pixel-level segmented into epithelium and stroma. Convolutional neural network and multiple instance learning were used to extract image features from original and segmented images. Patient-level classification models were trained to discriminate Luminal A versus B image features in tenfold cross-validation, with or without grade adjustment. The best-performing visual classifier was incorporated into envisioned diagnostic protocols as an alternative to genomic testing (PAM50) . The protocols were then compared in time-to-recurrence models.  \nResults Among ER+/HER2-tumors, the image-based protocol differentiated recurrence times with a hazard ratio (HR) of 2.81 (95% CI: 1.73–4. 56), which was similar to the HR for PAM50 (2 . 66, 95% CI: 1.65–4. 28) . Grade adjustment did not improve subtype prediction accuracy, but did help balance sensitivity and specificity. Among high grade participants, sensitivity and specificity (0 . 734 and 0.474, respectively) became more similar (0 .732 and 0. 624, respectively) in grade-adjusted models. The original and epithelium-specific images had similar performance and highest accuracy, followed by stroma or binarized images showing only the epithelial-stromal interface.  \nConclusions Given low rates of genomic testing uptake nationally, image-based methods may help identify ER+/ HER2-patients who could benefit from testing.  \nKeywords Breast cancer, CBCS3, Histology, Multiple instance learning, Image segmentation, Distance weighted learning  \n*Correspondence:  \nJ. S. Marron [marron@unc.edu](marron@unc.edu)[ ](marron@unc.edu)Melissa A. Troester [troester@unc.edu](troester@unc.edu)  \n1 Department of Biostatistics, University of North Carolina, Chapel Hill, NC, USA  \n2 Department of Statistics and Operations Research, University of North Carolina, Chapel Hill, NC, USA  \n3 Department of Epidemiology, University of North Carolina, Chapel Hill, NC, USA  \n4 Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA  \n5 Department of Genetics, University of North Carolina, Chapel Hill, NC, USA  \n6 Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC, USA  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this lic","cbCailfKCFZEN79p","https://ap.wps.com/l/cbCailfKCFZEN79p","pdf",7766474,11,"English","en",105,"# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Background\n## PAM50 subtypes and recurrence risk\n## Genomic testing limitations and hypothesis\n# Methods (protocol overview)\n## Reference protocol\n## Envisioned image-based approach","[{\"question\":\"How are breast cancer subtypes Luminal A and Luminal B classified in the study context?\",\"answer\":\"They are classified by the expression of PAM50 genes. The study considers how image-based learning might distinguish these subtypes for earlier, more practical risk identification.\"},{\"question\":\"What image processing and modeling approach was used with H\\u0026E slides?\",\"answer\":\"H\\u0026E images were pixel-level segmented into epithelium and stroma. Convolutional neural networks and multiple instance learning extracted features from both original and segmented images for patient-level classification.\"},{\"question\":\"How did the imaging-based protocol compare with PAM50 regarding recurrence risk?\",\"answer\":\"Among ER+/HER2-negative tumors, the image-based protocol differentiated recurrence times with a hazard ratio of 2.81, which was similar to the PAM50 hazard ratio of 2.66. Grade adjustment did not improve subtype accuracy but helped balance sensitivity and specificity.\"}]","Image analysis-based identification of high risk ER-positive, HER2-negative breast cancers - Research Open Access | PDF",1790011605,28,{"code":4,"msg":82,"data":83},"ok",{"site_id":75,"language":74,"slug":84,"title":65,"keywords":85,"description":66,"schema_data":86,"social_meta":140,"head_meta":142,"extra_data":144,"updated_unix":145},"image-analysis-based-identification-of-high-risk-er-positive-her2-negative-breast-cancers-research-open-access","",{"@graph":87,"@context":139},[88,102,122],{"@type":89,"itemListElement":90},"BreadcrumbList",[91,95,97,100],{"item":92,"name":93,"@type":94,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":96,"name":9,"@type":94,"position":14},"https://docshare.wps.com/document/",{"item":98,"name":40,"@type":94,"position":99},"https://docshare.wps.com/document/research-report/",3,{"item":101,"name":65,"@type":94,"position":19},"https://docshare.wps.com/document/image-analysis-based-identification-of-high-risk-er-positive-her2-negative-breast-cancers-research-open-access/335608/",{"url":101,"name":65,"@type":103,"image":104,"author":109,"headline":65,"publisher":111,"fileFormat":114,"inLanguage":74,"description":66,"dateModified":115,"datePublished":116,"encodingFormat":114,"isAccessibleForFree":117,"interactionStatistic":118},"DigitalDocument",{"url":105,"@type":106,"width":107,"height":108},"https://docshare.wps.com/thumbnails/image-analysis-based-identification-of-high-risk-er-positive-her2-negative-breast-cancers-research-open-access/335608.png","ImageObject",300,407,{"name":63,"@type":110},"Person",{"url":92,"name":112,"@type":113},"DocShare","Organization","application/pdf","2026-10-25","2026-09-21",true,{"@type":119,"interactionType":120,"userInteractionCount":29},"InteractionCounter",{"@type":121},"ViewAction",{"@type":123,"mainEntity":124},"FAQPage",[125,131,135],{"name":126,"@type":127,"acceptedAnswer":128},"How are breast cancer subtypes Luminal A and Luminal B classified in the study context?","Question",{"text":129,"@type":130},"They are classified by the expression of PAM50 genes. The study considers how image-based learning might distinguish these subtypes for earlier, more practical risk identification.","Answer",{"name":132,"@type":127,"acceptedAnswer":133},"What image processing and modeling approach was used with H&E slides?",{"text":134,"@type":130},"H&E images were pixel-level segmented into epithelium and stroma. Convolutional neural networks and multiple instance learning extracted features from both original and segmented images for patient-level classification.",{"name":136,"@type":127,"acceptedAnswer":137},"How did the imaging-based protocol compare with PAM50 regarding recurrence risk?",{"text":138,"@type":130},"Among ER+/HER2-negative tumors, the image-based protocol differentiated recurrence times with a hazard ratio of 2.81, which was similar to the PAM50 hazard ratio of 2.66. Grade adjustment did not improve subtype accuracy but helped balance sensitivity and specificity.","https://schema.org",{"og:url":101,"og:type":141,"og:title":65,"og:site_name":112,"og:description":66},"article",{"robots":143,"canonical":101},"index,follow",{"doc_id":61,"site_id":75},1790160332]